Rite Aid taps omnichannel veteran to fill new role of SVP brand development and innovation
CAMP HILL, Pa. — Rite Aid on Monday announced that David Abelman, a retail veteran with more than 25 years’ experience, is joining the company as SVP brand development and innovation. His appointment is effective immediately.
In this newly created position, Abelman will be responsible for overseeing the continued development of Rite Aid brand products as well as identifying and implementing new innovations to enhance and grow Rite Aid’s business. He will report to Ken Martindale, Rite Aid’s president and COO.
“David is a seasoned retail professional who brings broad-based marketing, merchandising and entrepreneurial experience to Rite Aid,” Martindale said. “His proven ability and experience will be a valuable asset to the company as an integral member of the management team focused on delivering the best products, service and care to meet our customers’ unique health and wellness needs.”
Most recently, Abelman was the CEO and co-founder of Self-Health Nation, a health and wellness omnichannel startup focused on providing nutritional advice and solutions. Prior to that position, he was EVP and chief merchandising and marketing officer for A.C. Moore Arts & Crafts. He has also held senior-level marketing and merchandising positions with Michaels Stores, Office Depot and Daymon Worldwide.
Rockin’ Green announces new detergent
SAN ANTONIO, Texas — Rockin’ Green, a supplier of eco-friendly cleaning products, announced the introduction of a new non-toxic Auto Dish detergent, available in a 16-oz. package. The detergent will be available in more than 60 Buy Buy Baby locations.
The new addition to the Rockin’ Green lineup to eliminate frustration in the dishwashing process, the company said, and can supply up to 30 loads per bag.
The detergent also is sold online for $12.95 at RockinGreenSoap.com
Study: One-third of initial prescriptions never filled
PHILADELPHIA — Medication nonadherence is common, but it may be reduced by lower drug costs and co-payments, as well as increased follow-up care, according to a study published earlier this week in the Annals of Internal Medicine.
Primary nonadherence was defined as not filling an initial prescription within nine months.
Overall, 31.3% of the 37,506 initial prescriptions written for the 15,961 patients were not filled, according to the study. Drugs in the upper quartile of cost were least likely to be filled, as were skin agents, gastrointestinal drugs and autonomic drugs, compared with anti-infectives.
An increase in adherence was associated with increasing patient age, elimination of prescription copayments for low-income groups and a greater proportion of all physician visits with the prescribing physician.
One limitation of the study was that patients’ rationale for choosing not to fill their prescriptions could not be measured, noted Robyn Tamblyn of McGill University, author of the study.